Valuation: Synovics Pharmaceuticals, Inc.

Market Cap 1.64M 1.44M 1.33M 1.23M 2.32M 157M 2.36M 15.88M 6.23M 77.11M 6.16M 6.03M 266M P/E 2007
-0.73x
P/E 2008 -2.06x
Enterprise Value 8.13M 7.13M 6.6M 6.08M 11.49M 778M 11.72M 78.71M 30.87M 382M 30.52M 29.86M 1.32B EV / Sales 2007
1.81x
EV / Sales 2008 0.6x
Free-Float
95.75%
Yield 2007 *
-
Yield 2008 -
Change 5-day change 1-year change 3-year change Capi.($)
-99.50%-.--% - - 3.65K
+0.00%-0.76%+49.00%+173.98% 1,060B
+0.32%-0.53%+64.50%+62.44% 619B
-0.46%-3.18%+28.79%+84.63% 438B
-1.75%-0.33%+28.33%+23.58% 333B
+0.24%-0.42%+29.19%+47.26% 282B
-1.75%-10.57%+18.27%+22.07% 267B
+0.67%+1.03%-26.81%-37.96% 218B
-1.34%-2.14%+20.73%+57.52% 196B
+0.87%+1.10%+16.90%+70.82% 161B
Average -10.21%-3.33%+25.43%+56.04% 397.1B
Weighted average by Cap. -0.20%-3.10%+35.79%+84.39%

Financials

2007 2008
Net sales 23.47M 20.58M 19.06M 17.54M 33.18M 2.25B 33.82M 227M 89.11M 1.1B 88.12M 86.19M 3.81B 25.96M 22.77M 21.09M 19.4M 36.7M 2.48B 37.42M 251M 98.58M 1.22B 97.48M 95.35M 4.21B
Net income -20.86M -18.29M -16.94M -15.59M -29.49M -2B -30.06M -202M -79.21M -980M -78.32M -76.61M -3.39B -4.01M -3.51M -3.25M -2.99M -5.66M -383M -5.77M -38.79M -15.21M -188M -15.04M -14.71M -650M
Net Debt 18.79M 16.48M 15.26M 14.04M 26.57M 1.8B 27.08M 182M 71.35M 883M 70.56M 69.02M 3.05B 6.49M 5.69M 5.27M 4.85M 9.17M 621M 9.35M 62.82M 24.64M 305M 24.36M 23.83M 1.05B
Logo Synovics Pharmaceuticals, Inc.
Synovics Pharmaceuticals, Inc. (Synovics) is a specialty pharmaceutical company engaged in the development, manufacturing and commercialization of generic over the counter (OTC) pharmaceutical products and generic prescription drug products. The Company is a manufacturer, packager and distributor of private label, or store brand, OTC products to chain drug stores, wholesalers and distributors throughout the United States. The Company’s OTC product categories include analgesics, cough and cold, antihistamines, asthma relief and laxatives. The Company has two primary subsidiaries, Kirk Pharmaceuticals, LLC (Kirk), and ANDAPharm, LLC (ANDAPharm). Kirk manufactures and distributes OTC products developed by or licensed to the Company. ANDAPharm serves as the product research and RX manufacturing arm of the Company with a focus on the development of active compounds for drugs.
Employees
-